Effects of selective thromboxane synthetase inhibitor and indomethacin on prostacyclin and thromboxane A2 from ischemic canine heart.
D015121:6-Ketoprostaglandin F1 alpha / Q000097:blood*; D000179:Acrylates / Q000494:pharmacology*; D000818:Animals; D003326:Coronary Circulation / Q000187:drug effects; D003327:Coronary Disease / Q000503:physiopathology*; D004285:Dogs; D006321:Heart / Q000187:drug effects / Q000503:physiopathology*; D007213:Indomethacin / Q000494:pharmacology*; D007700:Kinetics; D007773:Lactates / Q000097:blood; D019344:Lactic Acid; D008689:Methacrylates / Q000494:pharmacology*; D013928:Thromboxane A2 / Q000097:blood*; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors; D013931:Thromboxanes / Q000097:blood*
D000179:Acrylates; D007773:Lactates; D008689:Methacrylates; D013931:Thromboxanes; D019344:Lactic Acid; D013928:Thromboxane A2; D015121:6-Ketoprostaglandin F1 alpha; D013930:Thromboxane-A Synthase; C034364:ozagrel; D007213:Indomethacin